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Abstract
Objective—To determine factors associated with parental consent for their child’s participation
in a randomized, placebo-controlled trial.
Design—Cross-sectional survey.
Setting—7 Children’s Hospitals participating in a randomized trial evaluating management of
children with vesicoureteral reflux; July 2008 to May 2011.
Participants—Parents asked to provide consent for their child’s participation in the trial were
invited to complete an anonymous online survey about factors influencing their decision. 120
(44%) of the 271 invited, completed the survey: 58 of 125 (46%) had provided and 62 of 144
(43%) had declined consent.
Outcome Measures—60-question survey examining: child, parent, and study characteristics;
parental perception of the study; understanding of design; external influences; and decision-
making process.
Results—Having graduated from college and private health insurance were associated with
lower likelihood of providing consent. Parents who perceived the trial as having low degree of
risk, resulting in greater benefit to their child and other children, causing little interference with
standard care or exhibiting potential for enhanced care or who perceived the researcher as
professional were significantly more likely to consent to participate. Higher levels of
understanding of randomization process, blinding, and right to withdraw were significantly
associated with consent to participate.
Conclusions—Parents who declined consent had a relatively higher socioeconomic status, had
more anxiety about their decision and found it harder to make their decision compared with
consenting parents, who had higher levels of trust and altruism, perceived the potential for
enhanced care, reflected better understanding of randomization, and exhibited low decisional
uncertainty.
Keywords
Consent; randomized clinical trials; participation in pediatric clinical research
INTRODUCTION
Research to date of factors influencing a parent’s decision to provide consent for his or her
child to participate in clinical research has been limited to cancer studies and less-than-
minimal risk studies. Further, most investigators have collected data only from parents who
consented to their child’s involvement;1,2 very few have examined the motives of parents
who declined consent.3–5 The aggregate of reported findings suggests that the health of the
child, positive perceptions of the research team and consent process, and altruistic motives
play a significant role in the decision-making process.
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To evaluate decision-making among parents invited to enroll their child in a randomized
controlled trial of antimicrobial prophylaxis for vesicoureteral reflux, we developed and
administered a survey assessing the role of factors previously reported to influence parental
decision making. Our objective was to determine factors associated with parents’ decisions
to permit their child to participate or not participate in a randomized, placebo-controlled trial
and, accordingly, identify strategies to enhance enrollment in pediatric clinical research.
PATIENTS AND METHODS
Parents who were asked to provide consent for their child’s participation in a randomized
trial evaluating the management of children with vesicoureteral reflux (Randomized
Intervention for Children with VesicoUreteral Reflux, RIVUR, U01DK074053) were
eligible to participate in the consent survey. RIVUR is a randomized, placebo-controlled,
double-blind clinical trial evaluating the efficacy of long-term (24 months) antimicrobial
prophylaxis in preventing recurrent urinary tract infections and the occurrence of renal
scarring in children ages 2 months to 6 years old. Institutional Review Boards at each of the
participating institutions (Children’s Hospitals of Pittsburgh, Philadelphia, Buffalo, and
Chicago; Johns Hopkins University; Alfred I. duPont Hospital for Children; and Children’s
National Medical Center) determined this survey study to be exempt under 45 CFR
46.101(b)(2); investigators were required to read to parents an IRB-approved script that
contained basic elements of informed consent describing the anonymous survey, but no
formal written consent was obtained.
The RIVUR study was thoroughly discussed with parents of eligible children over the phone
or in person by an investigator, after which consent for their child participation was sought.
Regardless of whether they did or did not agree to their child’s participation, parents were
asked for permission to e-mail them a link to the survey. Parents were informed the
anonymous survey would take approximately 15 minutes to complete and involved
questions about age, race, education, family background, and their perceptions about
medical research; they were also informed that upon completing the survey, they would
receive a $10 gift certificate to an online bookstore retailer in appreciation for their time. At
one RIVUR study site (Children’s Hospital of Pittsburgh), parents who did not complete the
survey within 2 months of being sent the link to the online survey were reminded once; no
other sites sent out the link in a second wave, and no further reminders were sent to parents
in Pittsburgh.
The framework of our 60-question survey to assess factors influencing parental decisions to
participate in clinical research was informed by the conceptual model (Figure 1) we
developed based on prior studies.3 Parent, child, and study characteristics influence how
well parents understand the trial design issues, such as equipoise, randomization, blinding,
voluntary participation, and right to withdraw. This understanding, in turn, influences
parental perceptions regarding the risks and benefits of the trial. The decision to allow
participation is also influenced by parent decision-making style and by external influences.
We were interested in learning how factors in each stage of the decision-making process
influenced the final decision to provide or withhold consent. Altogether, we sought to
examine 7 constructs governing the decision to provide consent: child characteristics, parent
characteristics, study characteristics, parental perception of the study, parental understanding
of study design, external influences, and the decision-making process.
Survey questions included all those proposed by Tait et al.,3 though we modified the
wording of some questions and added 7 questions assessing parental understanding of the
trial. Study characteristics include the level of risk involved, study design, time requirement,
and characteristics of the consent environment and the researcher. Because we were only
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assessing participation in a single trial (RIVUR), we did not investigate the influence of
study characteristics on the decision-making process. Child characteristics included age, sex,
and whether the child was perceived by the parent to be sicker than other children
(vulnerable), whether the child provided assent, and whether the child had previously
participated in research. Relevant parent characteristics include demographics (age, sex,
ethnicity, race), socioeconomic status (education, health insurance), sense of altruism,
research experience (previous participation, trust), and style of decision-making.
Responses to most items were scored using a 5-point Likert scale (5 = strongly agree); some
items were scored on 0–10 visual analog scales (10 = high). A complete copy of the survey
and response data can be found in the Supplemental Information.
Faculty and staff from the University of Pittsburgh Clinical Translational Science Institute
Design, Biostatistics and Clinical Research Ethics Core, who were not involved in the
RIVUR study, were responsible for maintaining the anonymity of survey respondents,
implemented the survey, and analyzed the data. Web security met the University of
Pittsburgh standards of confidentiality.
Statistical Analysis
Basic descriptive statistics and frequencies were used to describe all variables, comparing
survey data from parents who consented to enroll their child in the RIVUR study with those
who declined consent. To determine which factors were significantly associated with the
decision to enroll their child in the RIVUR study, we used univariate analyses: Mann-
Whitney test for comparing continuous variables, and Chi-square or Fisher’s exact test for
categorical variables. Small cell size for some dichotomous variables precluded
multivariable logistic regression analysis. We tested each construct for internal reliability
using Cronbach alpha; in all cases, values obtained were >0.7, suggesting good internal
reliability. All analyses were conducted with SPSS version 19 (SPSS Inc., Chicago, IL). A P
value <0.05 was considered statistically significant.
RESULTS
Participants in the RIVUR study were enrolled at 19 participating institutions between May
2006 and May 2011; the survey study (an ancillary study to RIVUR) was conducted at only
7 of the 19 RIVUR participating institutions between July 2008 and May 2011. A total of
271 parents who had been contacted for consent to participate in the RIVUR study at one of
these 7 sites were e-mailed codes to participate in the online consent survey during the
survey study period. Of the 271 parents who were e-mailed codes for the online consent
survey, 120 (44%) completed the survey (84% from the Children’s Hospital of Pittsburgh
site): 58 of 125 (46%) parents who provided consent and 62 of 144 (43%) parents who
declined consent for their child to participate; the consent status of two participants was
unknown. The 271 parents who were e-mailed the consent survey at the 7 sites during the 3-
year period represent 21% of the approximately 1300 parents approached for their child’s
participation at the 19 RIVUR sites during the 5-year period. The 58 parents who consented
and filled the survey at the 7 sites during the 3-year period represent approximately 10% of
the 607 children enrolled at the 19 RIVUR sites during the 5-year period.
Parent and child demographic characteristics are shown in Table 1. Children whose parents
consented to their participation in the RIVUR trial were slightly older than those of non-
consenters; parents who consented were younger than non-consenters. Because
vesicoureteral reflux is three times more common in whites than blacks, the low minority
representation is expected.6 Having graduated from college and having private health
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insurance -- both proxies for higher socioeconomic status -- were associated with a lower
likelihood of consenting to their child’s participation in the RIVUR study.
In comparison, the RIVUR cohort of 607 children had a similar median age (1 year, range
0.2 – 5.9) and similar proportions of parents who were at least college graduates (48%) or
had public health insurance (29%) as the non-consenter survey study group. Compared with
each of the two survey study groups (consenters and non-consenters), the RIVUR cohort
was similarly composed of female subjects (92%), had a lower proportion of white race
subjects (81%), and a higher proportion of subjects with Hispanic ethnicity (13%).
Table 2 summarizes factors that influence the decision to provide consent. Parents were
significantly more likely to consent to participate if they perceived the researcher as being
friendly and professional and/or the RIVUR study as having a low degree of risk; resulting
in a greater benefit to their child and other children (higher altruism); causing little
interference with standard care; and/or exhibiting a greater potential for enhanced care.
External influences (discussing research with others, previous family or friends’ experience
with research) appeared not to influence consent to participate. Higher levels of parental
understanding of the randomization process, blinding, right to withdraw, and degree of risk
were also significantly associated with consent to participate; paradoxically, the higher
educated non-consenters displayed significantly lower understanding of study randomization
and blinding. We found a relatively low agreement (kappa 0.2) between parental
understanding of randomization and the perception that by participating in the study their
child will receive best medical care (therapeutic misconception).
Parents who had little decisional uncertainty (low levels of anxiety) were more likely to
consent to their child’s participation in the RIVUR study. Conversely, parents who declined
participation in the RIVUR study reported higher levels of anxiety and more difficulty
making the decision.
DISCUSSION
We found that parents who declined consent to their child’s participation in the RIVUR trial
had a relatively higher socioeconomic status, had more anxiety about their decision and
found it harder to make a decision about the study compared with consenting parents, who
exhibited higher levels of trust, altruism and low decisional uncertainty, perceived the
potential for enhanced care, and reflected better understanding of randomization.
The impact of socioeconomic status on research participation has varied. A higher level of
education resulted in higher research participation in HIV and cancer adult studies.7,8 In
contrast, in a randomized pediatric oncology study, parents with a higher socioeconomic
status were more likely to refuse participation,9 and parents with a bachelor’s degree or
higher were less likely to endorse research in an emergency setting than were parents with
less than a bachelor’s degree.10 In our study, better-educated non-consenters may have felt a
need to explain why they did not consent to the RIVUR trial, thus making them more likely
to participate in this survey. It is also possible that non-consenters with lower levels of
education were more likely to ignore the request to participate in survey. Accordingly,
caution should be applied when considering the influence of education on the consent
decision based on these data. In general, our findings may also be limited because we
solicited participation at just 7 of 19 study sites for only 3 of the 5 years during which the
RIVUR study was open for enrollment, and even among this selected sample, less than 50%
of parents who were invited completed the survey.
Previous reports have noted the significant influence of the child’s health on parental
decisions to provide consent.11–13 A strength of our study is that we surveyed consenting
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and non-consenting parents whose children were otherwise healthy, apart from
vesicoureteral reflux, and who were approached for participation in an actual rather than
hypothetical clinical trial.12,14
Three prior studies compared the motivations of consenting and non-consenting parents.
Tait et al.3 identified low perceived risk, degree to which the parent read the consent
document, characteristics of the consent document, parental understanding, perceived
importance of the study, and perceived benefits as predictors of providing consent. In a
British study4 of oral versus intravenous treatment for community-acquired pneumonia in
previously well children, altruism was the major motivation for parental consent; parents
who declined consent were unwilling to undergo randomization as they believed one
treatment arm (intravenous treatment) was superior, suggesting lack of understanding about
clinical trial design (equipoise). Harth et al.5 reported that the psychological profile of
volunteering parents differed from that of non-volunteering parents in the context of a
randomized trial of an asthma drug. Volunteering parents valued benevolence, were more
introverted, had lower self-esteem, and exhibited greater anxiety than non-volunteering
parents, who tended to have higher levels of education, hold professional/administrative
jobs, and exhibit greater social confidence and emotional stability. Our parents in both
categories did not differ in how they assessed equipoise (“Doctors do not really know which
of the two treatments is better”) and voluntary participation (“I felt like the decision to have
my child take part in the study was up to me”). In contrast, responses that reflected
understanding of study design issues – randomization, blinding, risk level, right to withdraw
(e.g., “My child has an equal chance of getting either treatment”), altruism, and potential
benefit to others were significantly higher among consenters (Table 2).
In studies conducted only among parents who had provided consent, factors influencing this
decision included altruistic motivation15,16 and a desire to learn more about their child’s
disease.1 In one study, the availability of a financial stipend or the parent’s educational level
were not felt to influence the consent decision, although obtaining free medication became
more important as socioeconomic status declined.1 Among educated “research-naïve”
parents who had consented to their child’s participation in placebo-controlled
gastrointestinal trials, motivation for consent derived from altruism and the setting and
manner in which consent had been sought; perceived risks (adverse effects, receipt of
placebo) and financial incentives did not play a significant role.2
Finally, in agreement with previous reports,2,3,16 we found that positive parental perception
of the researcher was associated with greater likelihood to consent. Specifically, parents
were asked if the “person who presented the study” was friendly, was professional, made
them feel comfortable, and “did a good job explaining the study.” These researcher
characteristics could have contributed to the consenting parents’ greater understanding of
and comfort with the clinical trial and its potential to benefit other children. Perez et al.2
note that comfort with the research team was high among all parents who enrolled their
children in a placebo-controlled trial but was lower among parents whose children did not
complete the study, emphasizing the importance of this initial encounter.
CONCLUSION
Findings from our survey may be used to improve participation in pediatric clinical research.
Among our families, important modifiable factors that influenced the consent process
included the involvement of a researcher who made them feel comfortable and proper
understanding of the study (i.e., low risk, lack of interference with standard of care, and
better understanding of randomization and blinding). Our findings emphasize the importance
of clearly explaining how risk is minimized, how participation affects standard of care,
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blinding and randomization, the right to withdraw at any time, and the benefits (if any) to
the child and other children. Our finding of high level of decisional anxiety among the more
educated and higher socioeconomic status parents provides an opportunity to acknowledge,
empathize, and support parents who may struggle with the decision. Careful consideration of
the various factors included in the conceptual model should enhance the quality of the
informed consent process and improve participation in pediatric clinical trials.
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Conceptual model (parenthetical numbers correspond with survey question numbers in the
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